ASPS Releases 2025 Plastic Surgery Statistics: The “GLP-1 Effect” and Shift Toward Restoration

Sep 4, 2026 | News

The American Society of Plastic Surgeons (ASPS) has officially released its 2025 Procedural Statistics Report, offering an in-depth analysis of surgical and non-surgical aesthetic trends nationwide. The data reveals an overall 7% increase in cosmetic surgical...

FDA Warns R3 Medical Companies Over Unapproved Regenerative Products

Sep 2, 2026 | Legal Compliance, News, Risk Management

The U.S. Food and Drug Administration (FDA) has issued a detailed Warning Letter (CBER 26-726330) to Scottsdale, Arizona-based R3 Medical Companies, its affiliated entities Bello Bio, LLC and Regen Suppliers, LLC, and CEO David L. Greene, M.D. Following joint facility...

Mississippi’s Medical Boards Draw a Hard Line on Research-Grade Peptides: What Med Spas and Wellness Clinics Need to Know

Sep 1, 2026 | Legal Compliance, News, State-Specific Regulations

Mississippi’s three healthcare licensing boards have put the state’s providers on notice: there is no safe harbor for offering “research-grade” peptides to patients. In a joint statement issued by the Mississippi State Board of Medical...

Revance and Teoxane Secure FDA Approval for RHA Redensity Eye: What Aesthetic Practices and Medical Directors Need to Know

Aug 21, 2026 | News, Risk Management

Revance Therapeutics and Teoxane have officially announced FDA approval for RHA Redensity® Eye, expanding the Teoxane RHA® Collection into the delicate infraorbital region. The hyaluronic acid (HA) filler is specifically indicated for correcting moderate to severe...

Eli Lilly Escalates Fight Against Black-Market Retatrutide: What Aesthetic Practices and Wellness Clinics Need to Know

Aug 13, 2026 | Legal Compliance, News

Eli Lilly & Co. has significantly escalated its legal campaign against the illicit trade of its investigational weight-loss drug, retatrutide. The pharmaceutical giant filed lawsuits in federal court against six U.S.-based businesses—including medical spas,...

The “Research Use Only” Myth: A Six-Year Prison Sentence and What the FDA’s Peptide Vote Actually Means

Aug 7, 2026 | Legal Compliance, News

Driven by booming consumer demand for anti-aging, weight-loss, and performance-enhancing therapies, integrative clinics, medical spas, and online vendors have rushed to offer popular compounds like BPC-157 and TB-500. Two recent developments expose a dangerous gap...